摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5S)-3-(2-phenylethyl)-5-[[5-(trifluoromethyl)pyridin-2-yl]oxymethyl]-1,3-oxazolidin-2-one | 1067242-04-9

中文名称
——
中文别名
——
英文名称
(5S)-3-(2-phenylethyl)-5-[[5-(trifluoromethyl)pyridin-2-yl]oxymethyl]-1,3-oxazolidin-2-one
英文别名
——
(5S)-3-(2-phenylethyl)-5-[[5-(trifluoromethyl)pyridin-2-yl]oxymethyl]-1,3-oxazolidin-2-one化学式
CAS
1067242-04-9
化学式
C18H17F3N2O3
mdl
——
分子量
366.34
InChiKey
LFKYUGGJWVKFGI-HNNXBMFYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    26
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    51.7
  • 氢给体数:
    0
  • 氢受体数:
    7

文献信息

  • OXAZOLIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11 -HYDROXYSTEROID DEHYDROGENASE TYPE I
    申请人:Institute Of Medicinal Molecular Design, Inc.
    公开号:EP2141154A1
    公开(公告)日:2010-01-06
    Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor. A compound represented by the formula: , its pharmaceutically acceptable salt, or a solvate thereof, wherein R1 is optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocycle or optionally substituted heterocyclealkyl, X is -O-, -NR3-, -NR3 C(=O)- or -NR3 S(=O)2-, R2 is optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl or optionally substituted heteroarylalkyl, R3 is hydrogen or optionally substituted alkyl.
    本发明公开了一种可用作 11β- 羟基类固醇脱氢酶 1 型抑制剂的化合物。 一种由式表示的化合物: 、其药学上可接受的盐或其溶液、 其中 R1 是任选取代的环烷基、任选取代的环烷基烷基、任选取代的杂环或任选取代的杂环烷基、 X 是-O-、-NR3-、-NR3 C(=O)- 或 -NR3 S(=O)2-、 R2 是任选取代的芳基、任选取代的芳烷基、任选取代的杂芳基或任选取代的杂芳基烷基、 R3 是氢或任选取代的烷基。
  • OXAZOLIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1
    申请人:Itai Akiko
    公开号:US20100113448A1
    公开(公告)日:2010-05-06
    Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor. A compound represented by the formula: its pharmaceutically acceptable salt, or a solvate thereof, wherein R 1 is optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocycle or optionally substituted heterocyclealkyl, X is —O—, —NR 3 —, —NR 3 C(═O)— or —NR 3 S(═O) 2 —, R 2 is optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl or optionally substituted heteroarylalkyl, R 3 is hydrogen or optionally substituted alkyl.
  • US7998992B2
    申请人:——
    公开号:US7998992B2
    公开(公告)日:2011-08-16
查看更多